サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1387489

ELISA法（酵素結合免疫吸着測定法）市場レポート：2030年までの動向、予測、競合分析

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.98円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

ELISA法（酵素結合免疫吸着測定法）市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年11月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

ELISA法（酵素結合免疫吸着測定法）の動向と予測

世界のELISA法市場は、2024年から2030年にかけてCAGR 7.5％で成長すると予測されます。この市場の主な促進要因は、HIV、デング熱、肝炎、マラリア、インフルエンザなどの感染症の流行と、複数の感染症を発症するリスクのある老人人口の増加です。世界のELISA法市場の将来は、病院・診断センター、製薬・バイオテクノロジー企業、学術研究センター、臨床検査室市場などのビジネスチャンスで有望視されています。

ELISA法市場の洞察

Lucintelの予測では、携帯性と継続的な技術進歩により、複数・ポータブルELISAが予測期間中に最も高い成長を遂げる見込みです。

この市場の中では、疾病の有病率の増加、個別化医療に対する需要の高まり、ELISA法に対する政府支援の増加により、病院・診断センターが最大のセグメントであり続けるでしょう。

北米は、高齢者人口の急増、医療機器の普及率の上昇、高度なヘルスケアインフラの存在により、予測期間中も最大地域であり続けると思われます。

本レポートでは、以下の11の主要な質問に回答しています：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のELISA法市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界のELISA法市場の動向（2018～2023年）と予測（2024～2030年）
  • タイプ別の世界のELISA法市場
    • サンドイッチELISA
    • 間接ELISA
    • 複数・ポータブルELISA
    • 競合ELISA
  • 用途別の世界のELISA法市場
    • 免疫
    • ワクチン開発
    • 感染症
    • がん
    • タンパク質定量
    • その他
  • 最終用途別の世界のELISA法市場
    • 病院・診断センター
    • 製薬・バイオテクノロジー企業
    • 学術研究センター
    • 臨床検査室
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界のELISA法市場
  • 北米のELISA法市場
  • 欧州のELISA法市場
  • アジア太平洋のELISA法市場
  • その他地域のELISA法市場

第5章 競合分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
    • タイプ別の世界のELISA法市場の成長機会
    • 用途別の世界のELISA法市場の成長機会
    • 最終用途別の世界のELISA法市場の成長機会
    • 地域別の世界のELISA法市場の成長機会
  • 世界のELISA法市場における新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のELISA法市場の能力拡大
    • 世界のELISA法市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific
  • BioMerieux
  • Sysmex Corporation
  • F. Hoffmann-La Roche
  • Danaher Corporation
  • Quidel Corporation
  • Bio-Rad Laboratories
  • Siemens Healthineers
  • Abbott Laboratories
目次

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Trends and Forecast

The future of the global enzyme-linked immunosorbent assay (ELISA) tests market looks promising with opportunities in the hospital and diagnostic center, pharmaceutical and biotech company, academic research center, and clinical laboratory markets. The global enzyme-linked immunosorbent assay (ELISA) tests market is expected to grow with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are growing prevalance of infectious diseases, such as HIV, dengue, hepatitis, malaria, influenza, and others and growing geriatric population who are at a risk of developing several infections.

A more than 150-page report is developed to help in your business decisions.

Enzyme-Linked Immunosorbent Assay (ELISA) Tests by Segment

The study includes a forecast for the global enzyme-linked immunosorbent assay (ELISA) tests by type, application, end use, and region.

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Sandwich ELISA
  • Indirect ELISA
  • Multiple and Portable ELISA
  • Competitive ELISA

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Immunology
  • Vaccine Development
  • Infectious Diseases
  • Cancer
  • Protein Quantitation
  • Others

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals and Diagnostic Centers
  • Pharmaceutical and Biotech Companies
  • Academic Research Centers
  • Clinical Laboratories
  • Others

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Enzyme-Linked Immunosorbent Assay (ELISA) Tests Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies enzyme-linked immunosorbent assay (ELISA) tests companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the enzyme-linked immunosorbent assay (ELISA) tests companies profiled in this report include-

  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific
  • Biomerieux
  • Sysmex Corporation
  • F. Hoffmann-La Roche
  • Danaher Corporation
  • Quidel Corporation
  • Bio-Rad Laboratories
  • Siemens Healthineers
  • Abbott Laboratories

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Insights

Lucintel forecasts that multiple and portable ELISA is expected to witness highest growth over the forecast period due to portability and on-going technological advancements.

Within this market, hospitals and diagnostic centers will remain the largest segment due to the increasing prevalence of diseases, rising demand for personalized medicine, and growing government support for ELISA testing.

North America will remain the largest region over the forecast period due to surge in geriatric population, rising penetration of medical devices, and presence of well-advanced healthcare infrastructure in this region.

Features of the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market

Market Size Estimates: Enzyme-linked immunosorbent assay (ELISA) tests market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Enzyme-linked immunosorbent assay (ELISA) tests market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Enzyme-linked immunosorbent assay (ELISA) tests market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the enzyme-linked immunosorbent assay (ELISA) tests market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the enzyme-linked immunosorbent assay (ELISA) tests market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for enzyme-linked immunosorbent assay (ELISA) tests market?

Answer: The global enzyme-linked immunosorbent assay (ELISA) tests market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the enzyme-linked immunosorbent assay (ELISA) tests market?

Answer: The major drivers for this market are growing prevalance of infectious diseases, such as HIV, dengue, hepatitis, malaria, influenza, and others and growing geriatric population who are at a risk of developing several infections.

Q3. What are the major segments for enzyme-linked immunosorbent assay (ELISA) tests market?

Answer: The future of the enzyme-linked immunosorbent assay (ELISA) tests market looks promising with opportunities in the hospital and diagnostic center, pharmaceutical and biotech company, academic research center, and clinical laboratory markets.

Q4. Who are the key enzyme-linked immunosorbent assay (ELISA) tests market companies?

Answer: Some of the key enzyme-linked immunosorbent assay (ELISA) tests companies are as follows:

  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific
  • Biomerieux
  • Sysmex Corporation
  • F. Hoffmann-La Roche
  • Danaher Corporation
  • Quidel Corporation
  • Bio-Rad Laboratories
  • Siemens Healthineers
  • Abbott Laboratories

Q5. Which enzyme-linked immunosorbent assay (ELISA) tests market segment will be the largest in future?

Answer: Lucintel forecasts that multiple and portable ELISA is expected to witness highest growth over the forecast period due to portability and on-going technological advancements.

Q6. In enzyme-linked immunosorbent assay (ELISA) tests market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to surge in geriatric population, rising penetration of medical devices, and presence of well-advanced healthcare infrastructure in this region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the enzyme-linked immunosorbent assay (ELISA) tests market by type (sandwich ELISA, indirect ELISA, multiple and portable ELISA, and competitive ELISA), application (immunology, vaccine development, infectious diseases, cancer, protein quantitation, and others), end use (hospitals and diagnostic centers, pharmaceutical and biotech companies, academic research centers, clinical laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type
    • 3.3.1: Sandwich ELISA
    • 3.3.2: Indirect ELISA
    • 3.3.3: Multiple and portable ELISA
    • 3.3.4: Competitive ELISA
  • 3.4: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Application
    • 3.4.1: Immunology
    • 3.4.2: Vaccine Development
    • 3.4.3: Infectious diseases
    • 3.4.4: Cancer
    • 3.4.5: Protein quantitation
    • 3.4.6: Others
  • 3.5: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use
    • 3.5.1: Hospitals and Diagnostic Centers
    • 3.5.2: Pharmaceutical and Biotech Companies
    • 3.5.3: Academic Research Centers
    • 3.5.4: Clinical Laboratories
    • 3.5.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Region
  • 4.2: North American Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
    • 4.2.2: North American Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others
  • 4.3: European Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
    • 4.3.1: European Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type: Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA
    • 4.3.2: European Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others
  • 4.4: APAC Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
    • 4.4.1: APAC Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type: Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA
    • 4.4.2: APAC Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others
  • 4.5: ROW Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
    • 4.5.1: ROW Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type: Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA
    • 4.5.2: ROW Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type
    • 6.1.2: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Application
    • 6.1.3: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use
    • 6.1.4: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Region
  • 6.2: Emerging Trends in the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Ortho Clinical Diagnostics
  • 7.2: Thermo Fisher Scientific
  • 7.3: BioMerieux
  • 7.4: Sysmex Corporation
  • 7.5: F. Hoffmann-La Roche
  • 7.6: Danaher Corporation
  • 7.7: Quidel Corporation
  • 7.8: Bio-Rad Laboratories
  • 7.9: Siemens Healthineers
  • 7.10: Abbott Laboratories